• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Editas Medicine, Inc. - Common Stock (NQ:EDIT)

2.050 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,073,837
Open 2.060
Bid (Size) 2.020 (100)
Ask (Size) 2.070 (200)
Prev. Close 2.050
Today's Range 1.970 - 2.080
52wk Range 0.9101 - 4.537
Shares Outstanding 81,632,619
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Editas (EDIT) Q2 2024 Earnings Call Transcript ↗
November 27, 2025
Editas (EDIT) Q2 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Editas Medicine Inc (NASDAQ:EDIT) Beats Q3 2025 Estimates and Provides Key Pipeline Update ↗
November 10, 2025
Editas Medicine beats Q3 2025 earnings estimates, reports strong revenue growth, and advances its lead gene-editing program, EDIT-401. 
Via Chartmill

Performance

YTD
N/A
N/A
1 Month
-13.3%
-13.3%
3 Month
-47.7%
-47.7%
6 Month
-19.3%
-19.3%
1 Year
+56.5%
+56.5%

More News

Read More
News headline image
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
November 10, 2025
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
November 06, 2025
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
News headline image
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
November 03, 2025
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗
October 27, 2025
Via Benzinga
News headline image
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
October 09, 2025
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
Editas Medicine Inc (NASDAQ:EDIT) Shows High Growth Momentum and Strong Technical Trend ↗
October 07, 2025
Via Chartmill
News headline image
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
October 06, 2025
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗
September 18, 2025
Via Benzinga
News headline image
Editas Medicine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
September 05, 2025
Via Benzinga
News headline image
Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
September 02, 2025
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
August 28, 2025
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
Editas Medicine to Participate in Upcoming Investor Conferences
August 27, 2025
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
Why Editas Medicine Stock Was Skyrocketing This Week ↗
August 15, 2025
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
August 13, 2025
Via Benzinga
News headline image
Top movers in Wednesday's session ↗
August 13, 2025
Via Chartmill
News headline image
Wednesday's session: gap up and gap down stocks ↗
August 13, 2025
Via Chartmill
News headline image
Editas Medicine Inc (NASDAQ:EDIT) Reports Mixed Q2 2025 Earnings: Revenue Beat but Wider Loss ↗
August 12, 2025
Via Chartmill
News headline image
Editas Medicine Announces Second Quarter 2025 Results and Business Updates
August 12, 2025
From Editas Medicine, Inc.
Via GlobeNewswire
News headline image
Can This Beaten-Down Stock Bounce Back? ↗
August 12, 2025
Via The Motley Fool
News headline image
Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now? ↗
June 28, 2025
Via The Motley Fool
Topics Workforce
News headline image
2 Beaten-Down Stocks to Avoid ↗
June 27, 2025
Via The Motley Fool
News headline image
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst ↗
June 18, 2025
Via Benzinga
News headline image
Editas Medicine Is Great. Here's Why You Shouldn't Buy It. ↗
June 17, 2025
Via The Motley Fool

Frequently Asked Questions

Is Editas Medicine, Inc. - Common Stock publicly traded?
Yes, Editas Medicine, Inc. - Common Stock is publicly traded.
What exchange does Editas Medicine, Inc. - Common Stock trade on?
Editas Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Editas Medicine, Inc. - Common Stock?
The ticker symbol for Editas Medicine, Inc. - Common Stock is EDIT on the Nasdaq Stock Market
What is the current price of Editas Medicine, Inc. - Common Stock?
The current price of Editas Medicine, Inc. - Common Stock is 2.050
When was Editas Medicine, Inc. - Common Stock last traded?
The last trade of Editas Medicine, Inc. - Common Stock was at 01/02/26 04:00 PM ET
What is the market capitalization of Editas Medicine, Inc. - Common Stock?
The market capitalization of Editas Medicine, Inc. - Common Stock is 167.35M
How many shares of Editas Medicine, Inc. - Common Stock are outstanding?
Editas Medicine, Inc. - Common Stock has 167M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap